Phase III study of veliparib with carboplatin and paclitaxel in HER2-negative advanced/metastatic gBRCA-associated breast cancer

CUPISCO: Identifying carcinoma of unknown primary patients according to ESMO guidelines

CheckMate 459: Safety and efficacy of nivolumab versus sorafenib as a first-line treatment in advanced hepatocellular carcinoma

INVICTUS: Assessing the safety and efficacy of ripretinib in patients with advanced gastrointestinal stromal tumours

Holistic management of patients with ALK-positive NSCLC

Precision medicine in ALK-positive NSCLC: Results from the BFAST trial

Prostate cancer updates: Advances in precision medicine and PARP inhibitors

Health-related quality of life for patients with metastatic pancreatic cancer: Updates from ESMO 2019

Key developments in pancreatic cancer from ESMO 2019

Breast cancer highlights from ESMO 2019

ClarIDHy: Targeted therapy ivosidenib for advanced cholangiocarcinoma

PARP inhibitor olaparib slows progression of advanced prostate cancer